» Articles » PMID: 33396906

MiR-146a Regulates Migration and Invasion by Targeting NRP2 in Circulating-Tumor Cell Mimicking Suspension Cells

Overview
Journal Genes (Basel)
Publisher MDPI
Date 2021 Jan 5
PMID 33396906
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer metastasis is the primary cause of cancer-related death and metastatic cancer has circulating-tumor cells (CTCs), which circulate in the bloodstream before invading other organs. Thus, understanding the precise role of CTCs may provide new insights into the metastasis process and reduce cancer mortality. However, the molecular characteristics of CTCs are not well understood due to a lack of number of CTCs. Therefore, suspension cells were generated from MDA-MB-468 cells to mimic CTCs, and we investigate the microRNA (miRNA)-dependent molecular networks and their role in suspension cells. Here, we present an integrated analysis of mRNA and miRNA sequencing data for suspension cell lines, through comparison with adherent cells. Among the differentially regulated miRNA-mRNAs axes, we focus on the miR-146a-Neuropilin2 (NRP2) axis, which is known to influence tumor aggressiveness. We show that miR-146a directly regulates NRP2 expression and inhibits Semaphorin3C (SEMA3C) signaling. Functional studies reveal that miR-146a represses SEMA3C-induced invasion and proliferation by targeting NRP2. Finally, high-NRP2 is shown to be associated with poor outcomes in breast cancer patients. This study identifies the key role of the miR-146a-NRP2 signaling axis that is critical for the regulation of migration and invasion in CTC-mimicking cells.

Citing Articles

Inhibition of Lymphangiogenesis: A Protective Role of microRNA 146a-5p in Breast Cancer.

Liang W, Wang H, Fu B, Song Y, Zhang Z, Liu X Breast J. 2025; 2024:7813083.

PMID: 39742358 PMC: 11357816. DOI: 10.1155/2024/7813083.


Orchestrating Resilience: How Neuropilin-2 and Macrophages Contribute to Cardiothoracic Disease.

Dhupar R, Powers A, Eisenberg S, Gemmill R, Bardawil C, Udoh H J Clin Med. 2024; 13(5).

PMID: 38592275 PMC: 10934188. DOI: 10.3390/jcm13051446.


MicroRNA-Mediated Regulation of Histone-Modifying Enzymes in Cancer: Mechanisms and Therapeutic Implications.

Szczepanek J, Tretyn A Biomolecules. 2023; 13(11).

PMID: 38002272 PMC: 10669115. DOI: 10.3390/biom13111590.


MicroRNAs as Molecular Biomarkers for the Characterization of Basal-like Breast Tumor Subtype.

Tariq M, Richard V, Kerin M Biomedicines. 2023; 11(11).

PMID: 38002007 PMC: 10669494. DOI: 10.3390/biomedicines11113007.


MicroRNA-154-5p suppresses cervical carcinoma growth and metastasis by silencing Cullin2 and .

Li Y, Wei Y, Zhang H, Bai Y, Wang X, Li Q PeerJ. 2023; 11:e15641.

PMID: 37397007 PMC: 10312157. DOI: 10.7717/peerj.15641.


References
1.
Huang S, Chi Y, Qin Y, Wang Z, Xiu B, Su Y . CAPG enhances breast cancer metastasis by competing with PRMT5 to modulate STC-1 transcription. Theranostics. 2018; 8(9):2549-2564. PMC: 5928908. DOI: 10.7150/thno.22523. View

2.
Hurst D, Edmonds M, Scott G, Benz C, Vaidya K, Welch D . Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res. 2009; 69(4):1279-83. PMC: 2754225. DOI: 10.1158/0008-5472.CAN-08-3559. View

3.
Dasgupta A, Lim A, Ghajar C . Circulating and disseminated tumor cells: harbingers or initiators of metastasis?. Mol Oncol. 2017; 11(1):40-61. PMC: 5423226. DOI: 10.1002/1878-0261.12022. View

4.
Liu Q, Wang W, Yang X, Zhao D, Li F, Wang H . MicroRNA-146a inhibits cell migration and invasion by targeting RhoA in breast cancer. Oncol Rep. 2016; 36(1):189-96. PMC: 4899025. DOI: 10.3892/or.2016.4788. View

5.
Si C, Yu Q, Yao Y . Effect of miR-146a-5p on proliferation and metastasis of triple-negative breast cancer via regulation of SOX5. Exp Ther Med. 2018; 15(5):4515-4521. PMC: 5920859. DOI: 10.3892/etm.2018.5945. View